Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6001
J&J Snack Foods
JJSF
$1.44B
| $1K | ﹤0.01% |
10
-3,504
| -100% | -$371K |
|
|
KE
6002
Kimball Electronics
KE
$591M
| $1K | ﹤0.01% |
+75
| New | +$849 |
|
|
TBHC
6003
DELISTED
The Brand House Collective
TBHC
| $1K | ﹤0.01% |
55
-76
| -58% | -$1.14K |
|
6004
Lennar Class B
LEN.B
$19.7B
| $1K | ﹤0.01% |
43
-28
| -39% | -$957 |
|
6005
LGI Homes
LGIH
$1.33B
| $1K | ﹤0.01% |
32
-1,972
| -98% | -$54.6K |
|
6006
CALL
Lumentum
LITE
$53.9B
| $1K | ﹤0.01% |
40
| – | – |
|
|
6007
PUT
Lumentum
LITE
$53.9B
| $1K | ﹤0.01% |
60
| – | – |
|
6008
Lantheus
LNTH
$6.58B
| $1K | ﹤0.01% |
+282
| New | +$648 |
|
6009
Lipocine
LPCN
$17.4M
| $1K | ﹤0.01% |
+23
| New | +$3.56K |
|
6010
Stride
LRN
$3.53B
| $1K | ﹤0.01% |
63
-1,834
| -97% | -$20.8K |
|
6011
Mercantile Bank Corp
MBWM
$1.03B
| $1K | ﹤0.01% |
+57
| New | +$1.35K |
|
6012
Marcus Corp
MCS
$912M
| $1K | ﹤0.01% |
24
-1,385
| -98% | -$27.2K |
|
6013
MacroGenics
MGNX
$240M
| $1K | ﹤0.01% |
30
-1,465
| -98% | -$33K |
|
|
MITT
6014
TPG Mortgage Investment Trust
MITT
$225M
| $1K | ﹤0.01% |
32
-1,175
| -97% | -$48.4K |
|
6015
MakeMyTrip
MMYT
$5.37B
| $1K | ﹤0.01% |
51
-439
| -90% | -$7.33K |
|
6016
Movado Group
MOV
$849M
| $1K | ﹤0.01% |
51
-759
| -94% | -$18.6K |
|
6017
Matrix Service
MTRX
$320M
| $1K | ﹤0.01% |
+48
| New | +$809 |
|
6018
Myers Industries
MYE
$1.24B
| $1K | ﹤0.01% |
+73
| New | +$1.01K |
|
6019
NACCO Industries
NC
$356M
| $1K | ﹤0.01% |
70
-206
| -75% | -$2.66K |
|
6020
Neurogene
NGNE
$670M
| $1K | ﹤0.01% |
11
+5
| +83% | +$795 |
|
6021
NovoCure
NVCR
$1.77B
| $1K | ﹤0.01% |
100
-26,772
| -100% | -$335K |
|
|
IMDX
6022
Insight Molecular Diagnostics
IMDX
$149M
| $1K | ﹤0.01% |
+15
| New | +$1.4K |
|
6023
OFG Bancorp
OFG
$2.22B
| $1K | ﹤0.01% |
156
-19,620
| -99% | -$160K |
|
|
ORC
6024
Orchid Island Capital
ORC
$1.32B
| $1K | ﹤0.01% |
+16
| New | +$829 |
|
6025
Pacira BioSciences
PCRX
$1.06B
| $1K | ﹤0.01% |
23
-70,524
| -100% | -$3.47M |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.